[144] IREN Limited SEC Filing

Rhea-AI Filing Summary

IREN Limited filed a Form 144 notifying the proposed sale of 1,000,000 ordinary shares through B. Riley Securities on NASDAQ with an approximate aggregate market value of $33,131,000. The filing lists total shares outstanding as 274,282,163 and an approximate sale date of 09/11/2025. Acquisition history for the shares to be sold is provided: 490,732 shares originally received from the issuer on 11/06/2018 and three restricted-stock-unit-related lots totaling 509,268 shares with acquisition dates in 06/19/2023 and 07/01/2023 (vested July 1, 2024) paid as remuneration. The filing also discloses recent related transactions: two option-related sales of 500,000 shares each on 09/03/2025 and 09/04/2025 with gross proceeds shown.

Positive

• Form 144 clearly identifies the broker (B. Riley Securities) and the exchange (NASDAQ) for the proposed sale
• Filing provides specific acquisition dates and payment types for the lots to be sold, aiding Rule 144 compliance review
• Disclosure includes recent related transactions with gross proceeds figures for option-related sales on 09/03/2025 and 09/04/2025

Negative

• None.

Insights

Financial Analyst

TL;DR

The Form 144 records a planned block sale of 1,000,000 IREN ordinary shares via B. Riley with an indicated market value of $33.13 million, and documents recent option-related disposals.

Detail: The filing supplies specific share counts, acquisition dates, and payment natures, allowing verification of Rule 144 eligibility windows for the lots disclosed. The reported outstanding share count provides context to the size of the proposed sale. Recent option exercises and reported gross proceeds on early-September sales are documented and relevant to near-term share supply.

Corporate Governance Expert

TL;DR

The notice is a routine insider sale disclosure that includes vesting and issuer-issued shares and confirms the signer asserts no undisclosed material adverse information.

Detail: The form includes a standard representation regarding material adverse information and references potential Rule 10b5-1 plans without providing plan adoption dates. The filing properly identifies the broker and supplies acquisition provenance for each lot, supporting compliance with disclosure requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	B. Riley Securities, Inc. 11100 Santa Monica Blvd. Suite 800 Los Angeles CA 90025	1000000	33131000.00	274282163	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	11/06/2018	Received directly from the issuer as subscriber shares	Issuer			490732	11/06/2018	Cash
Ordinary Shares	06/19/2023	Restricted stock units vested on July 1, 2024	Issuer			237722	06/19/2023	Remuneration
Ordinary Shares	07/01/2023	Restricted stock units vested on July 1, 2024	Issuer			271546	07/01/2023	Remuneration

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Awassi Capital Holdings 2 Pty Ltd., ATF Awassi Capital Trust #2 Level 6 55 Market Street Sydney C3 NSW 2000	Options to purchase ordinary shares expiring December 20, 2025	09/03/2025	500000	12757336.45
Awassi Capital Holdings 2 Pty Ltd., ATF Awassi Capital Trust #2 Level 6 55 Market Street Sydney C3 NSW 2000	Options to purchase ordinary shares expiring December 20, 2025	09/04/2025	500000	11765987.03

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the IREN Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 1,000,000 ordinary shares through B. Riley Securities on NASDAQ with an aggregate market value of $33,131,000 and an approximate sale date of 09/11/2025.

How many IREN shares are outstanding according to the filing?

The filing reports 274,282,163 shares outstanding.

What is the acquisition history for the shares being sold under the IREN Form 144?

The shares to be sold include 490,732 received directly from the issuer on 11/06/2018 and restricted-stock-related lots of 237,722 (06/19/2023) and 271,546 (07/01/2023) that vested on 07/01/2024 paid as remuneration.

Were there recent related sales by the filer before this Form 144?

Yes. The filing lists two option-related sales by Awassi Capital entities: 500,000 shares on 09/03/2025 (gross proceeds $12,757,336.45) and 500,000 shares on 09/04/2025 (gross proceeds $11,765,987.03).

Does the filing state whether a 10b5-1 trading plan was used?

The form references Rule 10b5-1 plans in the signature statement but does not provide a plan adoption date or explicit confirmation that a trading plan was adopted.

Who is the named broker for the proposed IREN share sale?

The named broker is B. Riley Securities, Inc. located at 11100 Santa Monica Blvd., Suite 800, Los Angeles, CA 90025.